...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >GABA(B) receptors modulate depolarization-stimulated ((3)H)glutamate release in slices of the pars reticulata of the rat substantia nigra.
【24h】

GABA(B) receptors modulate depolarization-stimulated ((3)H)glutamate release in slices of the pars reticulata of the rat substantia nigra.

机译:GABA(B)受体调节大鼠黑质网状切片中去极化刺激的((3)H)谷氨酸释放。

获取原文
获取原文并翻译 | 示例
           

摘要

GABA(B) receptors decrease the release of GABA from the striatal terminals within the pars reticulata of the substantia nigra by opposing the increase in the release caused by dopamine D receptors. The dopamine D receptors also increase the release of glutamate from subthalamic terminals in the pars reticulata. Because GABA(B) receptors decrease the glutamate release from these terminals, we have explored if the effect of GABA(B) receptors also opposed the effect of the dopamine D receptors. The effect of baclofen, a selective GABA(B)-receptor agonist, was tested on the release of [(3)H]glutamate caused by highly (40 mM) concentrated K(+) solutions in slices of the pars reticulata. Baclofen decreased (the concentration causing 50% inhibition, IC, was 8.15 muM) the increase in the release of the [(3)H]glutamate caused by the dopamine D receptors and it also decreased (IC was 0.51 muM) this release in the absence of the activation of the dopamine D receptors. The GABA(B) receptors appear then to inhibit glutamate release in two ways; one dependent on the activation of the dopamine D receptors and the other independent of such activation. The protein kinase A-inhibitor H89 blocked the increase in the release of the [(3)H]glutamate caused by the dopamine D receptors, though it did not block the dopamine D receptor-independent baclofen inhibition of the release. This finding indicates that this inhibition was not via the protein kinase A signal-transduction pathway. N-ethylmaleimide, an alkylating agent that inactivates pertussis toxin-sensitive Gi proteins, eliminated both the dopamine D receptor-dependent and -independent baclofen inhibition, showing that both were mediated by these proteins. The injection of baclofen into the pars reticulata of unanesthetized rats caused contralateral rotation, suggesting a reduced glutamate release from the subthalamic terminals, thereby stopping the inhibition of the premotor thalamic nuclei, causing locomotion. Our data suggest that GABA(B) receptors restrain the excitatory input from the subthalamic nucleus and stimulate motor behavior.
机译:GABA(B)受体通过阻止多巴胺D受体引起的释放增加而减少了黑质黑质网状纹状体末端GABA的释放。多巴胺D受体还增加了网状对虾的丘脑下丘脑中谷氨酸的释放。由于GABA(B)受体减少了这些末端的谷氨酸释放,因此我们探讨了GABA(B)受体的作用是否也与多巴胺D受体的作用相反。测试了巴氯芬(一种选择性的GABA(B)-受体激动剂)的作用,该释放是由高(40 mM)浓缩的K(+)溶液在网眼切片中引起的[(3)H]谷氨酸释放的。 Baclofen降低了(引起50%抑制的浓度,IC为8.15μM),由多巴胺D受体引起的[(3)H]谷氨酸盐的释放增加,并且在CD释放中也降低了(IC为0.51μM)。没有激活多巴胺D受体。然后,GABA(B)受体似乎以两种方式抑制谷氨酸盐的释放。一个依赖于多巴胺D受体的激活,另一个独立于这种激活。蛋白激酶A抑制剂H89阻止了由多巴胺D受体引起的[(3)H]谷氨酸盐释放的增加,尽管它没有阻止不依赖多巴胺D受体的巴氯芬的释放。该发现表明该抑制不是通过蛋白激酶A信号转导途径进行的。 N-乙基马来酰亚胺(一种使百日咳毒素敏感的Gi蛋白失活的烷基化剂)消除了多巴胺D受体依赖性和非依赖性的巴氯芬抑制作用,表明两者均由这些蛋白介导。将巴氯芬注射入未麻醉大鼠的网状对侧引起对侧旋转,表明从丘脑底下端释放的谷氨酸减少,从而停止了对运动前丘脑核的抑制,从而引起运动。我们的数据表明,GABA(B)受体抑制了丘脑下核的兴奋性输入并刺激了运动行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号